Europace

Europace 2001 3(1):29-38; doi:10.1053/eupc.2000.0136
© 2001 by European Society of Cardiology

This Article Abstract FREE Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (11) Request Permissions Disclaimer Google Scholar Articles by Notarius, C. F. Articles by Floras, J. S. Search for Related Content PubMed PubMed Citation Articles by Notarius, C. F. Articles by Floras, J. S. Social Bookmarking          What's this?

---

REVIEW

Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure

C. F. Notarius and J. S. Floras

Harrowston Heart Failure Clinic, Division of Cardiology, Mount Sinai and Toronto General Hospitals, University of Toronto Toronto, Ontario, Canada

Spectral analysis of heart rate variability has gained popularity as a simple, non-invasive tool for assessing autonomic function in both normal subjects and in patients in a variety of clinical settings. However, the use of this method as a means of estimating the magnitude of cardiac sympathetic activation in individual patients with heart failure has proved disappointing, with a lack of concordance with more direct measures of sympathetic outflow. This review will describe the rationale involved in using sympathetic indices obtained from spectral analysis of heart rate variability to assess cardiac sympathetic outflow in normal subjects and patients with heart failure. The specific limitations and technological concerns that dictate how it may most effectively be used in this patient population will be discussed.

Key Words: Heat rate variability, spectral analysis, heart failure, sympathetic nervous system

---

Correspondence: Catherine F. Notarius Ph.D., Clinical Cardiovascular Physiology Research Laboratory, Toronto General Hospital, 12ES-414, 200 Elizabeth St., Toronto, Ontario, M5G 2C4, Canada. E-mail: c.notarius{at}utoronto.ca

---

[1] Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178–193.

[2] Pomeranz B, Macaulay JB, Caudill MA, et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985; 248: H151–H153.

[3] Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science 1981; 213: 220–222.

[4] Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043–1065.

[5] Cloarec-Blanchard L, Funck-Brentano C, Lipski M, Jaillon P, Macquin-Mavier I. Repeatability of spectral components of short-term blood pressure and heart rate variability during sympathetic activation in healthy male subjects. Clin Sci 1997; 93: 21–28.

[6] Yamamoto Y and Hughson RL. Coarse-graining spectral analysis: new method for studying heart rate variability. J Appl Physiol 1991; 71: 1143–1150.

[7] Butler GC, Yamamoto Y, Xing HC, Northey DR, Hughson RL. Heart rate variability and fractal dimension during orthostatic challenges. J Appl Physiol 1993; 75: 2602–2612.

[8] Butler GC, Ando S, Floras JS. Fractal component of variability of heart rate and systolic blood pressure in congestive heart failure. Clin Sci 1997; 92: 543–550.

[9] Butler GC, Naughton MT, Rahman MA, Bradley TD, Floras JS. Continuous positive airway pressure increases heart rate variability in congestive heart failure. J Am Coll Cardiol 1995; 25: 672–679.

[10] Notarius CF, Butler GC, Ando S, Pollard MJ, Senn B, Floras JS. Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure. Clin Sci 1999; 96: 557–565.

[11] Goldberger AL. Fractal electrodynamics of the heartbeat. Ann NY Acad Sci 1990; 591: 402–409.

[12] van de Borne P, Montano N, Pagani M, Oren RM, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997; 95: 1449–1454.

[13] Mortara TA, La Rovere MT, Signorini MG, et al. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Br Heart J 1994; 71: 422–430.

[14] Scalvini S, Volterrani M, Zanelli E, et al. Is heart rate variability a reliable method to assess autonomic modulation in left ventricular dysfunction and heart failure? Assessment of autonomic modulation with heart rate variability. Int J Cardiol 1998; 67: 9–17.

[15] Ponikowski P, Anker SD, Chua TP, et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997; 79: 1645–1650.

[16] Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart). Circulation 1998; 98: 1510–1516.

[17] Szabo BM, van Veldhuisen DJ, van der Veer N, Brouwer J, De Graeff PA, Crijns HJG. Prognostic value of heart rate variability in chronic heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 1997; 79: 978–980.

[18] Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819–823.

[19] Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995; 92: 3206–3211.

[20] Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986; 73: 913–919.

[21] Rundqvist B, Elam M, Eisenhofer G, Friberg P. Normalization of total body and regional sympathetic hyperactivity in heart failure after transplantation. J Heart Lung Transplant 1996; 15: 516–526.

[22] Hara K and Floras JS. After-effects of exercise on hemodynamics and sympathetic nerve activity in young subjects with dilated cardiomyopathy. Heart 1996; 75: 602–608.

[23] Rundqvist B, Elam M, Bergman-Sverrisdottir Y, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997; 95: 169–175.

[24] Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73: 615–621.

[25] Ferguson DW, Berg WJ, Sanders JS. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol 1990; 16: 1125–1134.

[26] Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994; 90: 234–240.

[27] Grassi G and Esler M. How to assess sympathetic activity in humans. J Hypertens 1999; 17: 719–734.

[28] Stys A and Stys T. Current clinical applications of heart rate variability. Clin Cardiol 1998; 21: 719–724.

[29] Rimoldi O, Pierini S, Ferrari A, Cerutti S, Pagani M, Malliani A. Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs. Am J Physiol 1990; 258: H967–976.

[30] Montano N, Lombardi F, Gnecchi Ruscone R. Spectral analysis of sympathetic discharge, R-R interval and systolic arterial pressure in decerebrate cats. J Autonom Nerv Syst 1992; 40: 21–32.

[31] Nakamura Y, Yamamoto Y, Muraoka I. Autonomic control of heart rate during physical exercise and fractal dimension of heart rate variability. J Appl Physiol 1993; 74: 875–881.

[32] Floras JS, Butler GC, Ando S, Brooks SC, Pollard MJ. Comparison of sympathetic nerve activity and heart rate variability responses to lower body negative pressure.

[33] Miyajima E, Sawada R, Shigemasa T, Ishii M, Kawano Y, Tochikubo O. LF/HF ratio as an index of sympathetic nerve activity in humans. Hypertension 1997; 29: 908 (Abstract).

[34] Eckberg DL. Sympathovagal balance: A critical appraisal. Circulation 1997; 96: 3224–3232.

[35] Pagani M, Rimoldi O, Malliani A. Low-frequency components of cardiovascular variabilities as markers of sympathetic modulation. Trends Pharmacol Sci 1992; 13: 50–54.

[36] Pagani M, Lombardi F, Malliani A. Heart rate variability: disagreement on the markers of sympathetic and parasympathetic activities. J Am Coll Cardiol 1993; 22: 951–953.

[37] Pagani M, Montano N, Porta A, et al. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 1997; 95: 1441–1448.

[38] Gregoire J, Tuck S, Yamamoto Y, Hughson RL. Heart rate variability at rest and exercise: influence of age, gender, and physical training. Can J Appl Physiol 1996; 21: 455–470.

[39] Craft N and Schwartz JB. Effects of age on intrinsic heart rate, heart rate variability, and AV conduction in healthy humans. Am J Physiol 1995; 268: H1441–1452.

[40] Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482–492.

[41] Malik M and Camm J. Components of heart rate variability — what they really mean and what we really measure. Am J Cardiol 1993; 72: 821–822.

[42] Casadei B, Cochrane S, Johnston J, Conway J, Sleight P. Pitfalls in the interpretation of spectral analysis of the heart rate variability during exercise in humans. Acta Physiol Scand 1995; 153: 125–131.

[43] Piepoli M, Adamopoulos S, Bernardi L, Sleight P, Coats AJS. Sympathetic stimulations by exercise-stress testing and by dobutamine infusion induce similar changes in heart rate variability in patients with chronic heart failure. Clin Sci 1995; 89: 155–164.

[44] Warren JH, Jaffe RS, Wraa CE, Stebbins CL. Effect of autonomic blockade on power spectrum of heart rate variability during exercise. Am J Physiol 1997; 273: R495–R502.

[45] Azevedo ER, Newton GE, Floras JS, Parker JD. Reductions in filling pressure lower cardiac norepinephrine spillover in patients with chronic heart failure. Circulation 2000; 101: 2053–2059.

[46] Ando S, Dajani HR, Floras JS. Frequency domain characteristics of muscle sympathetic nerve activity in heart failure and healthy humans. Am J Physiol 1997; 273: R205–212.

[47] Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nerve activity in the failing human heart. J Am Coll Cardiol 1995; 26: 1257–1263.

[48] Kraemer MD, Kubo SH, Rector TS, Brunsvold N, Bank AJ. Pulmonary and peripheral vascular factors are important determinants of peak oxygen uptake in patients with heart failure. J Am Coll Cardiol 1993; 21: 641–648.

[49] Notarius CF, Ando S, Rongen GA, Senn B, Floras JS. Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects. Eur Heart J 1999; 20: 880–887.

[50] Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A sub-study of the studies of left ventricular dysfunction (SOLVD). Circulation 1990; 82: 1724–1729.

[51] Viquerat CE, Daly P, Swedberg K, et al. Endogenous catecholamine levels in chronic heart failure. Am J Med 1985; 78: 455–460.

[52] Kinugawa T, Ogino K, Kitamura H, et al. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure. Am J Med Sci 1996; 312: 110–117.

[53] Adamopoulos S, Piepoli M, McCance A, et al. Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1992; 70: 1576–1582.

[54] Saul JP, Rea RF, Eckberg DL, Berger RD, Cohen RJ. Heart rate and muscle sympathetic nerve variability during reflex changes of autonomic activity. Am J Physiol 1990; 258: H713–721.

[55] Kingwell BA, Thompson JM, McPherson GA, Kaye DM, Jennings GL, Esler MD. Comparison of heart rate spectral analysis with cardiac noradrenaline spillover and muscle sympathetic nerve activity in human subjects. In Di Rienzo M, Mancia G, Parati G, Pedotti A, Zanchetti A (Eds.). Computer Analysis of Cardiovascular Signals 1995; Amsterdam IOS Press pp. 167–176.

[56] Eisenhofer G, Friberg P, Rundqvist B, et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996; 93: 1667–1676.

[57] Newton GE and Parker JD. Acute effects of b₁-selective and nonselective b-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure. Circulation 1996; 94: 353–358.

[58] Watson-Wright W, Boudreau G, Cardinal R, Armour JA. b₁- and b₂-adrenoreceptor subtypes in canine intrathoracic efferent sympathetic nervous system regulating the heart. Am J Physiol 1991; 261: R1269–1275.

[59] Huang MH, Smith FM, Armour JA. Modulation of in situ canine intrinsic cardiac neuronal activity by nicotinic, muscarinic, and b-adrenergic agonists. Am J Physiol 1993; 265: R659–669.

[60] White M, Yanowitz F, Gilbert EM, et al. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 1995; 76: 1271–1276.

[61] Kienzle MG, Ferguson DW, Birkett C, Myers GA, Berg WJ, Mariano DJ. Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol 1992; 69: 761–767.

[62] Bigger JT, Steinman RC, Rolnitzky LM, Fleiss JL, Albrecht P, Cohen RJ. Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplants. Circulation 1996; 93: 2142–2151.

[63] Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85: 164–171.

[64] La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: 478–484.

[65] Lombardi F and Mortara A. Heart rate variability and cardiac failure. Heart 1998; 80: 213–214.

[66] Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991; 18: 464–472.

[67] Eaton GM, Cody RJ, Nunziata E, Binkley PF. Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive heart failure. Circulation 1995; 92: 555–561.

[68] Ishise H, Ananoi H, Ishizaka S, et al. Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J Appl Physiol 1998; 84: 1234–1241.

[69] Panina G, Knot U, Nunziata E, Cody RJ, Binkley PF. Role of spectral measures of heart rate variability as markers of disease progression in patients with chronic congestive heart failure not treated with angiotensin-converting enzyme inhibitors. Am Heart J 1996; 131: 153–157.

[70] Guzzetti S, Cogliati C, Turiel M, Crema C, Lombardi F, Malliani A. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. Eur Heart J 1995; 16: 1100–1107.

[71] Toepfer M, Meyer K, Maier P, et al. Heart rate variability and autonomic balance in patients with different stages of severe congestive heart failure. Clin Sci 1996; 91: 117.

[72] Szabo BM, van Veldhuisen DJ, Brouwer J, Haaksma J, Lie KI. Relation between severity of disease and impairment of heart rate variability parameters in patients with chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1995; 76: 713–716.

[73] Porter TR, Eckberg DL, Fritsch JM, et al. Autonomic pathophysiology in heart failure patients. Sympathetic-Cholinergic Interrelations. J Clin Invest 1990; 85: 1362–1371.

[74] Parker JD, Newton GE, Landzberg JS, Floras JS, Colucci WS. Functional significance of presynaptic a-adrenergic receptors in the failing and non-failing human left ventricle. Circulation 1995; 92: 1793–1800.

[75] Bibevski S and Dunlap ME. Ganglionic mechanisms contribute to diminished vagal control in heart failure. Circulation 1999; 99: 2958–2963.

[76] Azevedo ER and Parker JD. Parasympathetic control of cardiac sympathetic activity. Normal ventricular function versus congestive heart failure. Circulation 1999; 100: 274–279.

[77] Newton GE, Parker AB, Landzberg JS, Colucci WS, Parker JD. Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle. J Clin Invest 1996; 98: 2756–2763.

[78] Horner SM, Murphy CF, Coen B, et al. Contribution to heart rate variability by mechanoelectric feedback — Stretch of the sinoatrial node reduces heart rate variability. Circulation 1996; 94: 1762–1767.

[79] Sanderson JE, Yeung LYC, Yeung DTK, et al. Impact of changes in respiratory frequency and posture on power spectral analysis of heart rate and systolic blood pressure variability in normal subjects and patients with heart failure. Clin Sci 1996; 91: 35–43.

[80] Brown TE, Beightol LA, Koh J, Eckberg DL. Important influence of respiration on human R-R interval power spectra is largely ignored. J Appl Physiol 1993; 75: 2310–2317.

[81] Saul JP, Arai Y, Berger RD, Lilly LS, Colucci WS, Cohen RJ. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 1988; 61: 1292–1299.

[82] Ponikowski P, Chua TP, Amadi AA, et al. Detection and significance of a discrete very low frequency rhythm in RR interval variability in chronic heart failure. Am J Cardiol 1996; 77: 1320–1326.

[83] Mortara A, Sleight P, Pinna G, et al. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. Circulation 1997; 96: 246–252.

[84] Ponikowski P, Chua TP, Piepoli M, et al. Chemoreceptor dependence of very low frequency rhythms in advanced heart failure. Am J Physiol 1997; 272: H438–447.

[85] Ponikowski P, Anker SD, Chua TP, et al. Oscillatory breathing patterns during wakefulness in patients with chronic heart failure. Clinical implications and role of augmented peripheral chemosensitivity. Circulation 1999; 96: 246–252.

[86] Zhang Y, Song Y, Zhu J, Hu T, Wan L. Effects of enalapril on heart rate variability in patients with congestive heart failure. Am J Cardiol 1995; 76: 1045–1048.

[87] Kamen PW, Krum H, Tonkin AM. Low-dose but not high-dose captopril increases parasympathetic activity in patients with heart failure. J Cardiovasc Pharmacol 1997; 30: 7–11.

[88] Girgis I, Chakko S, de Marchena E, et al. Effect of clonidine on heart rate variability in congestive heart failure. Am J Cardiol 1998; 82: 335–337.

[89] Lin JL, Chan HL, Du CC, et al. Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: a longitudinal heart rate variability study. Am Heart J 1999; 137: 658–665.

[90] Tuininga YS, van Veldhuisen DJ, Brouwer J, et al. Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. Br Heart J 1994; 72: 509–513.

[91] Radaelli A, Coats AJS, Leuzzi S, et al. Physical training enhances sympathetic and parasympathetic control of heart rate and peripheral vessels in chronic heart failure. Clin Sci 1996; 91: 92–94.

[92] Toepfer M, Meyer K, Maier P, et al. Influence of exercise training and restriction of activity on autonomic balance in patients with severe congestive heart failure. Clin Sci 1996; 91: 116.

[93] Coats AJS, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992; 85: 2119–2131.

[94] Minotti JR and Massie BM. Exercise training in heart failure patients. Does reversing the peripheral abnormalities protect the heart? (Editorial). Circulation 1992; 85: 2323–2325.

[95] Kiilavuori K, Toivonen L, Naveri H, Leinonen H. Reversal of autonomic derangements by physical training in chronic heart failure assessed by heart rate variability. Eur Heart J 1995; 16: 490–495.

[96] Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61–66.

[97] van de Borne P, Montano N, Narkiewicz K, et al. Sympathetic rhythmicity in cardiac transplant recipients. Circulation 1999; 99: 1606–1610.

CiteULike    Connotea    Del.icio.us    What's this?

This article has been cited by other articles:

				J. S. Floras Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J. Am. Coll. Cardiol., July 28, 2009; 54(5): 375 - 385. [Abstract] [Full Text] [PDF]

				C L McGowan, J S Swiston, C F Notarius, S Mak, B L Morris, P E Picton, J T Granton, and J S Floras Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension Heart, May 1, 2009; 95(9): 754 - 758. [Abstract] [Full Text] [PDF]

				F. M. van der Sande, G. Wystrychowski, J. P. Kooman, L. Rosales, J. Raimann, P. Kotanko, M. Carter, C. T. Chan, K. M.L. Leunissen, and N. W. Levin Control of Core Temperature and Blood Pressure Stability during Hemodialysis Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 93 - 98. [Abstract] [Full Text] [PDF]

				C. T. Chan Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death? Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3061 - 3062. [Full Text] [PDF]

				S. Arora Autonomic imbalance in patients with takotsubo cardiomyopathy: cause or association? QJM, September 1, 2007; 100(9): 593 - 594. [Full Text] [PDF]

				C. F. Notarius and J. S. Floras Comment on Point:Counterpoint: "Cardiovascular variability is/is not an index of autonomic control of circulation" J Appl Physiol, June 1, 2007; 102(6): 2406 - 2406. [Full Text] [PDF]

				Y.J. Akashi, G. Barbaro, T. Sakurai, K. Nakazawa, and F. Miyake Cardiac autonomic imbalance in patients with reversible ventricular dysfunction takotsubo cardiomyopathy QJM, June 1, 2007; 100(6): 335 - 343. [Abstract] [Full Text] [PDF]

				J. Floras and A. Bagai Polyunsaturated Fatty Acids and the Post-Infarct Patient: A Recipe for Baroreflex Health? J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1607 - 1609. [Full Text] [PDF]

This Article Abstract FREE Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (11) Request Permissions Disclaimer Google Scholar Articles by Notarius, C. F. Articles by Floras, J. S. Search for Related Content PubMed PubMed Citation Articles by Notarius, C. F. Articles by Floras, J. S. Social Bookmarking          What's this?